ERVW-1 and AIDS: HIV entry into a host cell requires a critical membrane fusion process mediated by HIV envelope glycoprotein (Env) transmembrane subunit gp411,2, a direct target of HIV fusion inhibitors that are usually adopted to treat the AIDS patients without response to other antiretroviral therapeutics3,4,5.